Neuronetics (STIM) Price to Sales (2018 - 2026)

Neuronetics (STIM) has reported Price to Sales for 9 consecutive years, with 2.38 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales fell 60.64% year-over-year to 2.38 in Q2 2026; TTM through Jun 2026 was 0.64, a 69.25% decrease from a year earlier, with the FY2025 full-year figure at 0.64, down 6.43% from the prior year.
• Price to Sales was 2.38 for Q2 2026 at Neuronetics, down from 2.93 in the prior quarter.
• Over five years, Price to Sales peaked at 10.29 in Q4 2022 and troughed at 1.24 in Q3 2024.
• A 5-year average of 4.61 and a median of 4.58 in 2025 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales plunged 82.11% in 2022 and jumped 302.91% in 2025, its largest moves.
• Over 5 years, Price to Sales stood at 10.29 in 2022, then slumped by 59.65% to 4.15 in 2023, then tumbled by 45.31% to 2.27 in 2024, then rose by 0.33% to 2.28 in 2025, then rose by 4.56% to 2.38 in 2026.
• The last three Price to Sales figures came in at 2.38 (Q2 2026), 2.93 (Q1 2026), and 2.28 (Q4 2025), per Business Quant data.